Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions

World Vaccine Congress 2018

Meet with Q2 Solutions at the World Vaccine Congress 2018, booth#19, and learn how we can work with you to develop customized assays to meet your vaccine development goals

Washington, D.C. | April 03, 2018 - April 05, 2018 | 08:00 - 15:00 Add to Calendar
Schedule a Meeting

About This Event

Q2 Solutions’ tailored end-to-end solutions and global supply chain management can provide you with the strategic guidance and high-quality laboratory services you need to ensure regulatory success of your vaccines.

Our vaccine solutions span the entire development life cycle, including assay development, immunogenicity testing, genomic solutions, efficacy monitoring, project management and data management to meet your specific development needs.

Q2 Solutions has the deep scientific knowledge to provide best-in-class quality systems across our global network. We can help ensure your regulatory submission success through quality indicators for the provision of complete study samples integrity in management, containment and monitoring throughout your vaccine development efforts.

We can provide the insights and expertise for your study, to ensure and set global immunogenicity assay standards.

Make plans to join Q2 Solutions’ VP, Vaccines, Wayne Hogrefe, at his roundtable discussion, Aligning Sponsor/CRO/Laboratory Communication for Esoteric Laboratory Services, on Tuesday, April 3rd, at 11:20.

Some questions/issues the discussion would be aiming to address are:
  • How do you ensure the specific testing needs of a clinical trial sponsor is addressed by the testing laboratory?
  • What testing review processes have you found most reliable to ensure a quality result?
  • How do you align a sponsor, a CRO, and a central lab to ensure a successful delivery of data?
Schedule a meeting with Q2 Solutions at this year’s World Vaccine Congress, booth #19, to learn how our scientific experts can help you optimize your vaccine study designs and accelerate regulatory approval.

We look forward to meeting you in Washington, D.C.

Related Services:

Register for Event


Wayne R. Hogrefe, Ph.D

Dr. Hogrefe is the vice president of the vaccine unit at Q2 Solutions, a Quintiles Quest Joint Venture, where he has had overall business development responsibilities for the past ten years. Prior to his current role, he served multiple capacities in the reference laboratory and in vitro diagnostics business units of Focus Diagnostics, including director of Immunology, Laboratory Operations, Research and Development, and Technical Services and Scientific Affairs. Additionally, he is a diplomat of the American Board of Medical Laboratory Immunology. His research and assay development experience is in immunoassays for vaccine responses, vector-borne diseases, viral pathogens and emerging pathogens. These activities have led to several patents and more than 30 peer-reviewed publications.

Updated as of September 2018.

Assays to drive success in anti-infective and vaccine development

Extensive expertise for vaccine assay development and diagnostics

Q2 Solutions Anti-infective and Vaccine Development Services

Harnessing innovative technologies for clinical trials involving emerging and re-emerging infectious diseases

Tools for better management of infectious disease clinical trials

Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older

Q2 Solutions vaccine lab services play major part in establishing efficacy in trial for influenza vaccine development

Read More